Hans Peter Hasler, EVP, Global Neurology, Int'l at BIOGEN IDEC INC. (BIIB), sold 20,230 shares at $64.24 ($1.3M) on 2008-04-08, disclosed to the SEC on 2008-04-10.
Scheduled sale ($1.3M) by EVP, Global Neurology, Int'l under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.76 | 23 | $1K | 0.1% |
| 2 | $63.80 | 77 | $5K | 0.4% |
| 3 | $63.83 | 100 | $6K | 0.5% |
| 4 | $63.85 | 300 | $19K | 1.5% |
| 5 | $63.87 | 1,385 | $88K | 6.8% |
| 6 | $63.88 | 2,084 |
| $133K |
| 10.3% |
| 7 | $63.89 | 300 | $19K | 1.5% |
| 8 | $63.89 | 600 | $38K | 3.0% |
| 9 | $63.90 | 100 | $6K | 0.5% |
| 10 | $63.93 | 2,300 | $147K | 11.3% |
| 11 | $64.24 | 10,225 | $657K | 50.6% |
| 12 | $64.31 | 200 | $13K | 1.0% |
| 13 | $64.32 | 400 | $26K | 2.0% |
| 14 | $64.38 | 200 | $13K | 1.0% |
| 15 | $64.39 | 100 | $6K | 0.5% |
| 16 | $64.43 | 300 | $19K | 1.5% |
| 17 | $64.45 | 600 | $39K | 3.0% |
| 18 | $64.47 | 36 | $2K | 0.2% |
| 19 | $64.49 | 100 | $6K | 0.5% |
| 20 | $64.50 | 200 | $13K | 1.0% |
| 21 | $64.51 | 200 | $13K | 1.0% |
| 22 | $64.55 | 100 | $6K | 0.5% |
| 23 | $64.56 | 200 | $13K | 1.0% |
| 24 | $64.61 | 100 | $6K | 0.5% |
| Total | $64.14 avg | 20,230 | $1.3M | 100% |
| Filing → |
| BIIB | SELL | 2009-02-13 | $261K | — | Filing → |
| BIIB | SELL | 2008-11-07 | $37K | — | Filing → |
| BIIB | SELL | 2008-07-24 | $898K | — | Filing → |